Cellectis (CLLS) Cost of Revenue (2015 - 2023)

Cellectis' Cost of Revenue history runs 9 years deep, the most recent figure standing at -$344000.0 for Q4 2023.

• In Q4 2023, Cost of Revenue fell 149.86% year-over-year to -$344000.0; the TTM figure through Dec 2023 stood at $412000.0 (down 76.74% YoY), while the FY2023 annual figure was $737000.0, down 58.41% from the prior year.
• Cost of Revenue for Q4 2023 stood at -$344000.0, down from $367000.0 in the prior quarter.
• The five-year high for Cost of Revenue was $18.6 million in Q4 2020, with the low at -$344000.0 in Q4 2023.
• The 5-year median for Cost of Revenue is $752500.0 (2019), against an average of $4.0 million.
• The sharpest annual moves came in 2019 and 2023: Cost of Revenue jumped 685.0% in 2019, then tumbled 149.86% in 2023.
• Cellectis' Cost of Revenue stood at $5.7 million in 2019, then soared by 229.87% to $18.6 million in 2020, then tumbled by 98.7% to $243000.0 in 2021, then soared by 183.95% to $690000.0 in 2022, then sank by 149.86% to -$344000.0 in 2023.
• Business Quant data shows CLLS's Cost of Revenue at -$344000.0 in Q4 2023, $367000.0 in Q3 2023, and $55000.0 in Q2 2023.